Literature DB >> 3025872

Stable expression and replication of hepatitis B virus genome in an integrated state in a human hepatoma cell line transfected with the cloned viral DNA.

T Tsurimoto, A Fujiyama, K Matsubara.   

Abstract

A human hepatocellular carcinoma cell line (Huh6-c15) was transfected with a recombinant DNA molecule that consists of tandemly arranged hepatitis B virus (HBV) genome and a neomycin-resistant gene. One clone resistant to G-418 produces and releases surface antigen and e antigen into medium at a high level and accumulates core particles intracellularly. This clone has a chromosomally integrated set of the original recombinant DNA and produces a 3.5-kilobase transcript corresponding to the pregenome RNA as well as HBV DNAs in an extrachromosomal form. Most of these DNAs were in single-stranded or partially double-stranded form and were packaged in the intracellular core particles. In the medium, particles were detected that contained HBV DNA and were morphologically indistinguishable from Dane particles. These results demonstrate that the HBV genome in an integrated state acted as a template for viral gene expression and replication. The cells were maintained for more than 6 months without losing the ability to produce the extrachromosomal HBV DNA and Dane-like particles. Thus, the cells can be used as a model system for analyses of gene expression and DNA replication of HBV in human hepatocytes.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3025872      PMCID: PMC304224          DOI: 10.1073/pnas.84.2.444

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Demonstration of subpopulations of Dane particles.

Authors:  P M Kaplan; E C Ford; R H Purcell; J L Gerin
Journal:  J Virol       Date:  1976-03       Impact factor: 5.103

2.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

3.  Hepatitis B e antigen and infectivity of hepatitis B virus.

Authors:  T Shikata; T Karasawa; K Abe; T Uzawa; H Suzuki; T Oda; M Imai; M Mayumi; Y Moritsugu
Journal:  J Infect Dis       Date:  1977-10       Impact factor: 5.226

4.  Selective extraction of polyoma DNA from infected mouse cell cultures.

Authors:  B Hirt
Journal:  J Mol Biol       Date:  1967-06-14       Impact factor: 5.469

5.  Purification of naked intranuclear particles from human liver infected by hepatitis B virus.

Authors:  S Z Hirschman; M Gerber; E Garfinkel
Journal:  Proc Natl Acad Sci U S A       Date:  1974-09       Impact factor: 11.205

6.  Structure of hepatitis B Dane particle DNA and nature of the endogenous DNA polymerase reaction.

Authors:  T A Landers; H B Greenberg; W S Robinson
Journal:  J Virol       Date:  1977-08       Impact factor: 5.103

7.  DNA-mediated transfer of the adenine phosphoribosyltransferase locus into mammalian cells.

Authors:  M Wigler; A Pellicer; S Silverstein; R Axel; G Urlaub; L Chasin
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

8.  Expression of cloned hepatitis B virus DNA in human cell cultures.

Authors:  S Z Hirschman; P Price; E Garfinkel; J Christman; G Acs
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

9.  Biochemical and genetic evidence for the hepatitis B virus replication strategy.

Authors:  C Seeger; D Ganem; H E Varmus
Journal:  Science       Date:  1986-04-25       Impact factor: 47.728

10.  Hepatitis B surface antigen produced by a human hepatoma cell line.

Authors:  G M MacNab; J J Alexander; G Lecatsas; E M Bey; J M Urbanowicz
Journal:  Br J Cancer       Date:  1976-11       Impact factor: 7.640

View more
  74 in total

1.  Use of the hepatitis B virus recombinant baculovirus-HepG2 system to study the effects of (-)-beta-2',3'-dideoxy-3'-thiacytidine on replication of hepatitis B virus and accumulation of covalently closed circular DNA.

Authors:  W E Delaney; T G Miller; H C Isom
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

2.  Three envelope proteins of hepatitis B virus: large S, middle S, and major S proteins needed for the formation of Dane particles.

Authors:  K Ueda; T Tsurimoto; K Matsubara
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

3.  Chromosomal translocation and inverted duplication associated with integrated hepatitis B virus in hepatocellular carcinomas.

Authors:  T Tokino; S Fukushige; T Nakamura; T Nagaya; T Murotsu; K Shiga; N Aoki; K Matsubara
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

Review 4.  Animal models and the molecular biology of hepadnavirus infection.

Authors:  William S Mason
Journal:  Cold Spring Harb Perspect Med       Date:  2015-04-01       Impact factor: 6.915

5.  Complex regulation of transcription from the hepatitis B virus major surface antigen promoter in human hepatoma cell lines.

Authors:  A K Raney; D R Milich; A McLachlan
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

6.  Transcriptional activation and repression by cellular DNA-binding protein C/EBP.

Authors:  D Q Pei; C H Shih
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

7.  X gene-related sequences in the core gene of duck and heron hepatitis B viruses.

Authors:  M A Feitelson; R H Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

8.  Introduction of hepatitis delta virus into animal cell lines via cationic liposomes.

Authors:  V Bichko; H J Netter; J Taylor
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

9.  Novel nucleoside analogue MCC-478 (LY582563) is effective against wild-type or lamivudine-resistant hepatitis B virus.

Authors:  Suzane Kioko Ono-Nita; Naoya Kato; Yasushi Shiratori; Flair José Carrilho; Masao Omata
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

10.  Efficient duck hepatitis B virus production by an avian liver tumor cell line.

Authors:  L D Condreay; C E Aldrich; L Coates; W S Mason; T T Wu
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.